Mandate

Vinge advises owner in connection with sale of Kung Markatta

May 06, 2013

Vinge has advised Ekomodern F, W & E AB in connection with the sale of Kung Markatta AB to Priveq Investment Fund IV. The company’s current indirect owners, i.e. Peter Enberg, Stefan Wilhelmson and CEO Anders Dahlin, will retain significant shareholdings through a new holding company formed in conjunction with the acquisition.

Kung Markatta is a market leader in Sweden within the distribution and marketing of ecological and natural products. The company, which was established in Örebro in 1983, has expanded significantly since it was acquired in 2004 by Peter Enberg and his partners. In addition to its own well-renowned range of approximately 150 ecological products under the Kung Markatta trade mark, the company also markets a large portfolio of other brands such as, among others, Alpro, Rice Dream, Yogi Tea, and Green & Black’s.  The company’s turnover in 2012 was approximately SEK 200 million and it currently employs 30 people.

Vinge’s team consisted of partner Daniel Rosvall together with, among others, associates Kristian Ford, Markus Larsson and Maria Dahlin.     

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026